Introduction {#s1}
============

The establishment of functional neuronal networks relies on the correct incorporation of a neuron into a developing circuit. An extended neurite network enables a single neuron to process information from multiple input cells and to relay that information to a wide range of targets. Neurite formation during development is a dynamic process and therefore tight regulation seems necessary to achieve connection specificity. At earlier steps of circuit formation, axon guidance, an intensively investigated process, combines intrinsic factors and extracellular cues to form a trajectory towards the general target area ([@bib60]; [@bib48]; [@bib30]; [@bib40]). Subsequently, the formation of precise axonal connections within the target area relies on the development of the correct number of axonal branches. Currently, the mechanisms regulating axonal branch number and accuracy are largely unknown and subject to much debate.

In mammals, a common mechanism to regulate axon branch number is excessive axonal outgrowth and exuberant branch formation during development followed by a refinement process called pruning ([@bib35]). Pruning encompasses the removal of relatively short axon terminals and branch arbors innervating a common target area as seen in the mouse peripheral and central nervous systems ([@bib46]; [@bib23]). In addition, long axon collaterals innervating distant target areas occurring for example in corticospinal tract (CST) axons of layer V neurons can be eliminated ([@bib58]). Removal of short redundant or inappropriate branches occurs typically via retraction of short branches whereas longer tracts are eliminated primarily by degeneration ([@bib36]). A process involving features of both pruning mechanisms, termed axosome shedding, has been observed in mammals ([@bib3]).

An important question is how branch refinement is regulated. For a long time activity-dependent mechanisms were thought to be the major factor underlying regulation of pruning in the mammalian system ([@bib38]; [@bib64]; [@bib28]; [@bib23]). However, several studies in various vertebrate systems suggest that this may not be universally true ([@bib10]; [@bib2]; [@bib41]; [@bib7]; [@bib52]; [@bib57]). Thus, although there is ample description of axonal branch refinement in vertebrate systems, much remains to be elucidated about the mechanisms underlying them.

In *Drosophila* deterministic genetic programs are thought to account for the stereotypic development of the vast majority of neuronal connections ([@bib29]; [@bib25]). Nevertheless, a specialized form of pruning also occurs in *Drosophila*, namely the widely studied remodeling of insect networks during metamorphosis. In holometabolous insects, like the fruit fly, many cells need to accommodate two distinct morphological and behavioral states within a lifetime. In the nervous system neuronal arbors have to remodel extensively to allow the reiterative use of larval neuronal populations to form adult circuits. Interestingly, the molting hormone Ecdysone is not only necessary for body transformation but also for the regulation of remodeling events in the nervous system ([@bib53]). This system resembles partially the emergence of an adult network from initial projections as seen in vertebrates in the visual and motor cortex ([@bib39]).

In this study, we focus on axonal branch refinement of the dorsal cluster neurons (DCNs) in the central nervous system (CNS) of *Drosophila* ([@bib24]). DCNs form only adult-specific neuronal projections and therefore unlike sensory neurons ([@bib59]) and mushroom body neurons ([@bib5]), DCN axons are not remodeled during metamorphosis. DCN axons innervate the optic lobes via an initial phase of long-range axonal growth and retraction steps, followed by the establishment of a stereotypic number of axonal branches by an unknown mechanism. In this work, we first describe that this wiring pattern is achieved through initially excessive axonal branch growth followed by refinement during brain development. Next, we show that the refinement process is regulated through local activation of EGFR signaling in part by EGF-secreting sensory axons. We find that EGFR shows intrinsic differential distribution between individual developing DCN axonal branches and that the appropriate level of signaling is required for proper axonal branching. Mechanistically, we find that, in this context, the EGFR acts via regulating actin cytoskeleton dynamics, and not the canonical mitogen activated kinase (MAPK) pathway. Finally, high-resolution 4D live imaging of pupal brain explants shows that inhibition of EGFR signaling causes a dramatic reduction in axonal branch dynamics leading to the failure of axonal branch pruning.

Results {#s2}
=======

Dorsal cluster neurons as a model to study axonal branch formation {#s2-1}
------------------------------------------------------------------

The dorsal cluster neurons (DCNs) establish a complex neurite network in the *Drosophila* adult optic lobes. A small subset of neurons from this cluster extend their axons in the outer part of the optic lobe, the medulla (Me) ([@bib50]; [@bib32]), where they form a stereotypic pattern of axonal branches ([Figure 1A,B](#fig1){ref-type="fig"}). This pattern can be readily visualized using the *ato-Gal4* driver in combination with a UAS-driven marker of choice such as CD8-GFP. Flip-out single cell clones ([@bib62]) reveal the branch pattern of an individual axon derived from a single neuron of the 12 medulla innervating DCNs ([Figure 1C](#fig1){ref-type="fig"}). False color labeling and tracing ([@bib34]) of single DCN Me axons and their branches ([Figure 1D](#fig1){ref-type="fig"}) reveals that each axon generates 6--8 primary branches, with a mean of 7 branches. This stereotypic pattern is achieved by hot spots of branches extending in dorsal and ventral direction from each main axon shaft. The first main branch point is located at the border between lobula and Me with one or two branches. The next major branch point with often two branches is situated in Me layers M7--M8 and in this location branches from distinct neighboring axons are often in close contact forming a grid-like pattern. The terminal set of up to four branches is distributed over the M1--M3 layers and is more often intermingled with neighboring axon branches. In between the two most distal branch points intermediate branches occur occasionally. DCN branches never extend beyond the Me neuropil.10.7554/eLife.01699.003Figure 1.The axonal network of medulla dorsal cluster neurons (DCNs) in the adult central nervous system of Drosophila.(**A**) Dorsal cluster neurons, labeled with lacZ (red) using the atoGal4-14a driver, with its dendritic and axonal projections in the optic lobes of the CNS. Using the FLP-out system, an individual neuron is labeled with mCD8-GFP (green) within the background of the entire cluster. AtoGal4-14a is used in all the following experiments except when stated otherwise. (**B**) DCN axons, labeled with mCD8-GFP, form a stereotypic pattern of axonal branches within the medulla (Me) of the adult optic lobe. (**C**) Using the FLP-out system the axon and branches of an individual neuron are labeled with mCD8-GFP (green) within the background of the entire cluster labeled with lacZ (red). (**D**) False color labeling of one Me DCN axon with its main shaft (green) and branches (magenta) using a tracer tool. The scale bars represent 100 µm in (**A**) and 20 µm in (**B**--**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.01699.003](10.7554/eLife.01699.003)

EGFR signaling regulates axon branch formation {#s2-2}
----------------------------------------------

We carried out a targeted screen using loss and gain of function transgenes for signal transduction and axon guidance receptors to identify pathways that might regulate axon branch development. We noted excessive branching in the adult DCNs using a dominant-negative construct of the EGFR. To validate these findings we first analyzed flies carrying a viable hypomorphic loss of function mutation for the receptor (EGFR^T1^). In this genetic background DCN axons show short ectopic branches ([Figure 2A](#fig2){ref-type="fig"}) highlighted using the tracing tool ([Figure 2A′](#fig2){ref-type="fig"}). Since the proper development of the optic lobes depends on EGFR signaling ([@bib27]), reduced EGFR signaling might indirectly influence DCN axon formation and morphology. To investigate whether the EGFR is required in the DCNs for axonal branch refinement, we sought to generate DCN MARCM EGFR-null clones ([@bib33]), whereby EGFR function is removed at the time of neuronal birth. We obtained very few clones, suggesting that the EGFR may be required early during development for cell viability. The clones we did obtain showed ectopic branching defects, but also severe axon targeting phenotypes, suggesting that the EGFR is required early in DCN development and precluding further analysis of these clones ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To avoid these early defects, we used the *ato-Gal4* driver, which is expressed in postmitotic DCNs after the initiation of axonal outgrowth ([@bib50]; [@bib65]; [@bib32]), to express two different dominant negative alleles of the EGFR (uas-EGFR^DN-A^, [@bib16]; uas-EGFR^DN-B^, [@bib6]) and *EGFR*^*RNAi*^ (uas-EGFR^RNAi^, VDRC107130). In all three cases the DCNs show a significant increase of axon branches in the adult CNS. Compared to an average of 7 primary branches under wild type conditions, we observed a significant increase to 10.5 primary branches per axon in EGFR^DN-A^ expressing DCNs ([Figure 2B,B′,E](#fig2){ref-type="fig"}). Single cell clones in wild type ([Figure 2F](#fig2){ref-type="fig"}) and EGFR^DN−A^ background ([Figure 2G](#fig2){ref-type="fig"}) show the branch increase on single cell level. Expression of the second, weaker, EGFR^DN^ allele ([@bib54]) (EGFR^DN-B^) resulted in an increase to an average of 8.3 branches per axon ([Figure 2C,C′,E](#fig2){ref-type="fig"}), and EGFR knock-down with RNAi leads to a similar increase to 8.5 branches per axon ([Figure 2D,D′,E](#fig2){ref-type="fig"}). In the case of the EGFR^DN-A^ axonal branches appear thin and spike-like suggesting that they are immature. Interestingly, inhibition of EGFR results not only in an increase of the average branch number, but also increases the variability in the branch numbers between individual axons ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), even within the same individual brain, suggesting that EGFR signaling may regulate the accuracy and robustness of the branching process.10.7554/eLife.01699.004Figure 2.EGF-receptor downregulation in the DCNs results in excessive axonal branches in the adult.(**A**) The homozygous hypomorphic allele EGFR^T1^ shows additional, short branches. (**B**--**D**) Downregulation of the EGFR specifically in the DCNs results in an increase of adult branches via overexpression of (**B**) a dominant-negative form **A** (UAS-EGFR^DN-A^), (**C**) a dominant-negative form **B** (UAS-EGFR^DN-B^) and (**D**) a RNAi against EGFR (UAS-EGFR^RNAi^). (**A′**--**D′**) Visualization of branches (purple) along a single main axon shaft (green) using the tracing tool reveals excessive branches of the aforementioned genotypes in (**A**--**D**). (**E**) Quantification of adult primary branch numbers per axon for the genotypes shown in (**B**--**D**) shows significant increase of branches. Control 6.96 ± 1.34 (n = 60), EGFR^DN-A^ 10.5 ± 2.5 (n = 45, p\<0.001) EGFR^DN-B^ 8.3 ± 1.46 (n = 40, p\<0.001), *EGFR*^*RNAi*^ 8.5 ± 1.09 (n = 40, p\<0.001). (**F**--**G**) Adult Drosophila brain in which the neuropil is marked with DN-Cad (red). Flip out DCN clones are generated in control (**F**) and EGFR^DN−A^ (**G**) background. Error bars represent SEM. Non-parametric ANOVA Kruskal--Wallis test. \*\*\*p\<0.001. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.004](10.7554/eLife.01699.004)10.7554/eLife.01699.005Figure 2---figure supplement 1.EGFR^null^ MARCM clones show early branch growth defects.(**A**) Example of an adult Drosophila brain in which a single GFP-positive EGFR mutant DCN is generated using the MARCM technique. (**A′**) High magnification of the axonal projection of the clone in (**A**) in the contralateral brain half. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.005](10.7554/eLife.01699.005)10.7554/eLife.01699.006Figure 2---figure supplement 2.Spi release from photoreceptor axons regulates DCN axon branch pruning.(**A**) The homozygous, hypomorphic allele Spi^scp2^ shows ectopic short branches. (**A′**) Visualization of branches (purple) along a single main axon shaft (green), using the tracing tool. (**B**--**D**) Co-innervation of DCN axon branches (green) and photoreceptor axons (anti-chaoptin, red) in the medulla at 36 hr APF (**B**), at 48 hr APF (**C**) and adult (**D**). (**E**) Vein-LacZ expression in unknown cells, probably glia, very close to the more proximal branches of the DCNs, suggesting that Vein may be the other ligand activating EGFR in the DCNs. (**F**--**G**) No difference in branch number was observed after downregulation of *Spi* using UAS-*Spi*^*RNAi*^ in the DCNs using the ato-Gal4-14a. (**H**--**I**) *Spi* downregulation in photoreceptors using the GMR-Gal4 driver causes a significant increase in DCN branches whereby DCN axons are labeled with LexAop-myr-GFP driven by an IMAGO LexA knock-in into the *atonal* locus (ato^lexA^). (**J**) Analysis of the RNAi experiment represented in (**F**--**I**). Significant increase of DCN branch numbers occurs only after photoreceptor specific *Spi* downregulation. Control (atoGal4-14a\>UAS-CD8-GFP) 5.6 ± 1.1 (n = 12), *Spi*^*RNAi*^ (atoGal4-14a\>UAS-Spi^RNAi^) 5.9 ± 1.1 (n = 12), control (GMR-Gal4\>UAS-CD8-GFP) 5.42 ± 0.9 (n = 12), *Spi*^*RNAi*^ (GMR-Gal4\>UAS-Spi^RNAi^) 7.17 ± 2.17 (n = 12). Error bars represent SEM. *t* test. \*p\<0.05. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.006](10.7554/eLife.01699.006)10.7554/eLife.01699.007Figure 2---figure supplement 3.Distribution of axon branch numbers in control and EGFR-DN flies.Inhibition of EGFR signalling in the DCNs increases both the average number and the variability of axonal branch numbers.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.007](10.7554/eLife.01699.007)

Activation of the EGFR requires binding to its EGF ligands. To confirm that EGFR signaling regulates DCN axon branching, we first tested adult hypomorphic mutants for the EGFR ligand Spitz (Spi) whose role in optic lobe development is well described (reviewed in [@bib44]). Reduction of Spi activity results in ectopic short branches indistinguishable from those seen in EGFR hypomorphic mutants ([Figure 2---figure supplement 2A,A](#fig2s2){ref-type="fig"}′; compare to [Figure 2A,A′](#fig2){ref-type="fig"}). To determine the source of the EGF signal that regulates DCN branch refinement, we considered two possibilities. First, DCN axons themselves might release an activating ligand to initiate an autocrine signaling mechanism, as seen in the p75-TNR axo-axonal competition of mouse and rat sympathetic axons innervating the eye ([@bib49]). Second, neurons in the target neuropil might release EGF to regulate branch refinement. A subset of retinal photoreceptors known as R8 and R7 have axon terminals that innervate the medulla. Photoreceptors are known to secrete Spi to initiate a number of EGFR-dependent events in the developing optic lobes ([@bib26]; [@bib27]; [@bib63]). We analyzed the coincidence of innervation of the medulla by R7 and R8 photoreceptor axons using the photoreceptor specific marker mAb 24B10 ([@bib17]). Overlap between DCN and R7/8 axons can be seen at different times during brain development and in the adult brain ([Figure 2---figure supplement 2B--D](#fig2s2){ref-type="fig"}).

To distinguish between the two models, we used *Spi*^*RNAi*^ driven by either ato-Gal4 (DCNs) or GMR-Gal4 (photoreceptors) to down regulate *Spi* expression in the DCNs or photoreceptors, respectively. To visualize DCN branch formation while down regulating *Spi* specifically in the photoreceptors, we used the Gal4-independent LexA-based binary expression system ([@bib31]). Specifically, we took advantage of the *ato*^*LexA*^ IMAGO ([@bib9]) knock-in allele we recently generated ([@bib32]) and used it to drive LexAop-GFP expression in DCNs. Whereas we find no significant difference in branch number upon knock-down of *Spi* in the DCNs ([Figure 2---figure supplement 2F,G,J](#fig2s2){ref-type="fig"}), *Spi* knock-down in photoreceptors causes a significant increase in DCN branches ([Figure 2---figure supplement 2H,I,J](#fig2s2){ref-type="fig"}). In addition, to Spi release from photoreceptors, we observed cells expressing a reporter for the EGFR ligand Vein in close proximity to DCN axons ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}), suggesting a second source of EGF within the brain. Taken together, these results show that EGFR signaling regulates DCN axonal branch development.

EGFR is required for developmental axon branch pruning {#s2-3}
------------------------------------------------------

In theory, the adult branching pattern of DCN medulla axons can be established via one of at least two distinct mechanisms during development. On the one hand, accurate target innervation might proceed via the direct formation of the correct number of branches. Alternatively, the specificity of axonal branching might be the result of initial excessive outgrowth and exuberant branch formation during development followed by a refinement process to eliminate the majority of branches, as in refinement observed in mammalian visual map formation ([@bib14]), for example.

To distinguish between these two models, we characterized branching of wild type DCN axons at different time points after puparium formation (APF) during brain development. Between 36 hr and 54 hr APF DCN axons form extensive branches at multiple positions along the growing axon ([Figure 3A--C](#fig3){ref-type="fig"}). Between 60 hr and 72 hr APF pruning begins to be evident ([Figure 3D--F](#fig3){ref-type="fig"}′). At 84 hr APF, the eventual adult branch pattern of 6--8 branches is apparent ([Figure 3G](#fig3){ref-type="fig"}) and little or no further pruning appears to occur beyond that point ([Figure 3H,I](#fig3){ref-type="fig"}). This developmental pattern is not an artifact of the expression of the membrane bound marker CD8-GFP, as two other intracellular axonal markers (nSyb-GFP and Syt-GFP) yield the same results ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).10.7554/eLife.01699.008Figure 3.Loss of EGFR function impairs developmental axon branch pruning.(**A**--**I**) Axonal branch pattern at different pupal stages shows excessive branching at early to mid-pupal development. Successive refinement of exuberant branches can be observed between 60 hr and 96 hr (arrowhead, compare **D**--**H**). Branch morphology at (**A**) 36 hr APF, (**B** and **B′**) 48 hr APF, (**C**) 54 hr APF, (**D**) 60 hr APF, (**E**) 64 hr APF, (**F** and **F′**) 72 hr APF, (**G**) 84 hr APF, (**H**) 96 hr APF and (**I**) adult stage. High magnification of branches is shown in **B′** and **F′**. (**J**--**O**) Axonal branch pattern at different pupal stages of EGFR^DN^ expressing DCNs shows excessive branching at early to mid-pupal time points similar to wild type. Impaired refinement of exuberant branches can be observed between 60 hr and 96 hr (arrow, compare **L**--**O**). Branch morphology at (**J**) 36 hr APF, (**K** and **K′**) 48 hr APF, (**L**) 60 hr APF, (**M** and **M′**) 72 hr APF, (**N**) 84 hr APF, (**O**) 96 hr APF. High magnification of branches is shown in **K′** and **M′**. (**P**) Quantification of branches at the second branch point at 48 hr and 72 hr APF comparing control and EGFR^DN^ using the Skeleton Analysis tool of ImageJ ('Materials and methods'). EGFR downregulation does not result in increased branches at 48 hr APF compared to control. Significant decrease of developmental branch numbers at 72 hr APF occurs due to refinement in control. No significant decrease in branch number was observed after EGFR downregulation between 48 hr and 72 hr APF. Compared to control more branches persist after EGFR downregulation at 72 hr APF. Control (48 hr APF) 49.33 ± 9.87 (n = 18), control (72 hr APF) 22.75 ± 9.1 (n = 18, p\<0.01), EGFR^DN^ (48 hr APF) 45.77 ± 10.96 (n = 16), EGFR^DN^ (72 hr APF) 37.3 ± 3.83 (n = 14) (to control 72 hr APF, p\<0.05). Error bars represent SEM. *t* test. \*p\<0.05; \*\*p\<0.01. The scale bars represent 20 µm except in **B′**, **K′** and **M′** with 10 µm. (**Q**) Schematic representation of the role of EGFR signaling in DCN axonal branch formation.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.008](10.7554/eLife.01699.008)10.7554/eLife.01699.009Figure 3---figure supplement 1.DCN axon branches.(**A**--**F**) DCN axon branches labeled with nSyb-GFP during pupal development at (**A**) 36 hr APF, (**B**) 48 hr APF, (**C**) 60 hr APF, (**D**) 72 hr APF, (**E**) 84 hr APF, (**F**) 96 hr APF. (**G**--**L**) DCN axon branches labeled with nSyb-GFP during pupal development at (**G**) 36 hr APF, (**H**) 48 hr APF, (**I**) 60 hr APF, (**J**) 72 hr APF, (**K**) 84 hr APF, (**L**) 96 hr APF. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.009](10.7554/eLife.01699.009)10.7554/eLife.01699.010Figure 3---figure supplement 2.Branch growth is not enhanced in aged EGFR^DN^ flies.(**A**) DCN axon branching (green) of 2-days-old EGFR^DN^ flies does not exceed the neuropil marked with DN-cadherin (red). (**B**) DCN axon branching (green) of aged EGFR^DN^ flies at 18 days does not exceed the neuropil marked with DN-cadherin (red). The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.010](10.7554/eLife.01699.010)

Excessive axonal branches in EGFR mutant adults may be the result either of increased branch growth or of failure of branch pruning. To distinguish between these two possibilities, we analyzed DCNs expressing EGFR^DN^ during pupal development. Between 36 hr and 48 hr APF axon branching at the second branch point is similar to wild type ([Figure 3J,K](#fig3){ref-type="fig"}). An initial difference in branch phenotype can be observed at 60 hr APF and subsequently at 72 hr APF, the typical refinement seen in wild type is largely absent in the EGFR^DN^ background ([Figure 3L--M](#fig3){ref-type="fig"}′). The failure to prune is evident at 84 hr and 96 hr APF ([Figure 3N,O](#fig3){ref-type="fig"}) where DCN axons show excessive axonal branches. To rule out developmental delay as a cause we examined 2-day vs 18-day-old EGFR^DN^ flies. These flies are indistinguishable from 96 hr APF EGFR^DN^ flies indicating no further branch refinement ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Finally, we quantified axonal branch pruning at 48 hr and 72 hr APF by counting the number of branch end-points at these two time points in wildtype and EGFR^DN^ flies, respectively. While there is no significant difference between the two genotypes at 48 hr APF, quantification at 72 hr APF confirms the increased amount of branches in the EGFR^DN^ background compared to wild type ([Figure 3P](#fig3){ref-type="fig"}). In addition, the significant decrease in branch number seen in wild type axons between 48 hr and 72 hr is not observed in the EGFR^DN^ axons ([Figure 3P](#fig3){ref-type="fig"}). In summary, these data show that EGFR signaling is required to generate the correct number of axonal branches through the reduction of branch precursors formed during development ([Figure 3Q](#fig3){ref-type="fig"}).

Asymmetry of EGFR localization regulates differential filopodial dynamics {#s2-4}
-------------------------------------------------------------------------

To gain insight into the role of EGFR during axonal branching, we turned to primary embryonic *Drosophila* neuronal culture ([@bib42]; [@bib45]). After 2 days in culture wildtype *Drosophila* primary neurons sprout on average ∼2.5 primary axonal branches, whereas neurons expressing EGFR^DN^ show a significant increase in branch number ([Figure 4A--C](#fig4){ref-type="fig"}), suggesting that regulation of axonal branching by the EGFR is a process intrinsic to neurons and common to different neuronal subtypes. Axonal branches develop from dynamic filopodia that gets stabilized during the axonal branching process. We quantified the dynamics of filopodia under WT and EGFR loss of function conditions. We find that in growing wildtype neurons less than 10% of filopodia are static during the imaging time window of 3 min. In contrast, EGFR^DN^ neurons have a significant increase in the percentage of static filopodia to ∼30% ([Figure 4D--F](#fig4){ref-type="fig"}). An increase in static filopodia may suggest that more of the transient protrusions are stabilized into branches. An indication of the maturation of filopodia into branches is the invasion of microtubules into axonal filopodia ([@bib19]). Accordingly, we find that EGFR^DN^ induces an increase in microtubules invading axonal filopodia ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These data suggest that EGFR signaling regulates branch formation by controlling the dynamics of immature protrusions. To examine the localization of the EGFR in primary neurons, we cultured neurons from animals expressing C-terminally GFP-tagged EGFR (UAS-EGFR^GFP^) and performed live imaging experiments. We find that the EGFR is dynamically transported into and out of axonal branches and their filopodia ([Figure 5A](#fig5){ref-type="fig"}; [Video 1](#video1){ref-type="other"}, [Video 2](#video2){ref-type="other"}), with slightly, but significantly, higher levels in dynamic filopodia compared to static filopodia ([Figure 5A′,A″](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In summary, our data indicate that EGFR is differentially localized to static vs dynamic filopodia and that its activity promotes dynamic filopodial behavior and consequent adjustment of branch number.10.7554/eLife.01699.011Figure 4.EGFR regulates filopodia dynamics in primary Drosophila neuronal cultures.(**A** and **B**) Branch formation in cultured primary Drosophila neurons (2 days). (**B**--**B′**) Overexpression of UAS-EGFR^DN^ using the *sca-Gal4* driver results in an increase of branches when compared to (**A**--**A′**) wild type (control). For the visualization of branches, neurons were stained with anti-tubulin (green) and phalloidin (magenta). (**C**) Quantification of primary branch numbers per axon shows significant increase of branches in UAS-EGFR^DN^ neurons (control: 2.48 ± 0.2 (n = 83); EGFR^DN^: 3.57 ± 0.24; n = 74, p\<0.001). (**D**--**E**) Still images from videos of (**D**) wild type and (**E**) UAS-EGFR^DN^-expressing neurons. Overexpression of UAS-EGFR^DN^ using the *sca-Gal4* driver results in a decrease of filopodia dynamics in primary Drosophila neurons cultured for 6--8 hr. Different filopodia are marked by colored arrows and can be followed over time. (**F**) Quantification of static vs dynamic (extensions and retractions) behaviors shows a significant distribution change between wild type vs EGFR^DN^-expressing filopodia (control: static = 10, dynamic = 110; EGFR^DN^: static = 41, dynamic = 86, p\<0.001). Error bars represent SEM. Mann--Whitney test. \*\*\*p\<0.001. The scale bars in (**A**--**B**) represent 10 µm and in (**D**--**E**) represent 3 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.011](10.7554/eLife.01699.011)10.7554/eLife.01699.012Figure 4---figure supplement 1.Increase in filopodia containing microtubules by expression of UAS-EGFR^DN^.(**A** and **B**) Filopodia containing microtubules in cultured primary Drosophila neurons (6 hr). (**B**) Overexpression of UAS-EGFR^DN^ using the *sca-Gal4* driver results in an increase of filopodia containing microtubules (arrowhead) when compared to (**A**) wild type (control). Neurons were stained with anti-tubulin (green) and phalloidin (magenta). (**C**) Quantification of filopodia containing microtubules, the percentage of filopodia with microtubules is increase in UAS-EGFR^DN^ neurons (in percentages, control: 13 ± 0.8 (n = 253); EGFR^DN^: 17 ± 0.7; n = 239, p\<0.001). Error bars represent SEM. Mann--Whitney test. \*\*\*p\<0.001. The scale bars in (**A** and **B**) represent 3 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.012](10.7554/eLife.01699.012)10.7554/eLife.01699.013Figure 5.EGFR shows differential localization in filopodia of primary Drosophila neurons.(**A**--**B**) UAS-EGFR^GFP^ expressed with elav-Gal4 in wild type (**A**) and EGFR^DN^ (**B**) primary Drosophila neurons. False color image displaying a heat map of an EGFR^GFP^-expressing growth cone. EGFR^GFP^ expression in dynamic (**A′** and **B′**) and static filopodia (**A″** and **B″**) is followed over time in wild type (**A′** and **A″**) and EGFR^DN^ (**B′** and **B″**). **A′** and **B′** each shows one filopodia growing and one retracting (**C**). To quantify EGFR^GFP^ intensity in static vs dynamic filopodia in the absence (control) or presence of EGFR^DN^, we calculated the ratio of EGFR^GFP^ in dynamic minus static filopodia (GFP maximal intensity of each dynamic phase minus the mean of GFP maximal intensity in static filopodia). The difference in EGFR^GFP^ levels between dynamic filopodia and static filopodia are significantly reduced in the presence of EGFR^DN^ (control dynamic-static: 0.1046 ± 0.009, n=216; EGFR^DN^ dynamic-static: 0.0349 ± 0.0121, n=124, p\<0.001). Error bars represent SEM. Mann---Whitney test. \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.013](10.7554/eLife.01699.013)10.7554/eLife.01699.014Figure 5---figure supplement 1.Localization of EGFR in cultured neurons.*UAS-EGFR*^*GFP*^ under control of *sca*-Gal4 is significantly higher expressed in dynamic filopodia compared to static filopodia in cultured wild-type neurons.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.014](10.7554/eLife.01699.014)10.7554/eLife.01699.015Figure 5---figure supplement 2.Colocalization of EGFR with Rab11 and Rab5 in the growth cone.(**A**--**B**) Growth cones from primary Drosophila neurons expressing UAS-EGFR^GFP^ with elav-Gal4*.* Neurons were inmunostained for the recycling endosomal marker Rab11 (**A**, **B**, **A‴**, **B‴** in red), GFP (**A′**, **B′**, **A‴**, **B‴** in green) and the early endosomal marker Rab5 (**A″**, **B″**, **A‴**, **B‴** in blue). Note that a fraction of EGFR granules colocalises with Rab11 (arrows) or Rab5 (arrowheads). The scale bars in (**A**) represent 1 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.015](10.7554/eLife.01699.015)Video 1.EGFR-GFP cell culture filopodia.This video is related to [Figure 5](#fig5){ref-type="fig"}. Live imaging time-lapse video of axons from different primary neurons grown in culture for 4 days. UAS-EGFR^GFP^ is expressed with elav-Gal4 driver. Images were collected every 4 s.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.016](10.7554/eLife.01699.016)10.7554/eLife.01699.016Video 2.EGFR-GFP cell culture filopodia.This video is related to [Figure 5](#fig5){ref-type="fig"}. Live imaging time-lapse video of axons from different primary neurons grown in culture for 4 days. UAS-EGFR^GFP^ is expressed with elav-Gal4 driver. Images were collected every 4 s.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.017](10.7554/eLife.01699.017)10.7554/eLife.01699.017

We wondered whether differential EGFR localization is itself dependent on EGFR signaling activity. To this end, we compared levels of EGFR^GFP^ in filopodia of control vs EGFR^DN^ neurons. We find that the difference in EGFR^GFP^ levels between dynamic and static filopodia drops dramatically upon inhibition of EGFR signaling ([Figure 5B,B′,B″,C](#fig5){ref-type="fig"}). EGFR signaling depends on receptor endocytosis upon ligand binding ([@bib21]). Interestingly, EGFR^GFP^ traffics actively all along the axonal shafts, branches and filopodia in cultured neurons ([Video 3](#video3){ref-type="other"}), and we find EGFR-GFP puncta partially co-localize with both Rab5 and Rab11, suggesting that EGFR is present on early and recycling endosomes ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). These data indicate that recycling might lead to differential EGFR localization in filopodia. Because the EGFR^DN^ used here can still bind ligand but fails to signal, one interesting possibility is that these dominant negative receptors may titrate ligand away from the functional receptor and thus inhibit not only signaling, but also internalization. To test the putative role of endocytosis in receptor dynamics, we live-imaged EGFR^GFP^ localization in filopodia before and after inhibition of endocytosis using the Dynamin inhibitor Dyngo ([@bib22]). In untreated wild type neurons, EGFR^GFP^ levels vary between individual filopodia and within each filopodium over time ([Figure 6A--C](#fig6){ref-type="fig"}). Upon inhibition of endocytosis, the overall levels of EGFR^GFP^ in filopodia decrease and the fluctuation of EGFR^GFP^ between and within filopodia is significantly reduced ([Figure 6A′--C](#fig6){ref-type="fig"}). This is accompanied by a dramatic reduction in filopodial dynamics ([Figure 6D](#fig6){ref-type="fig"}; [Video 4](#video4){ref-type="other"}), suggesting that receptor endocytosis and recycling regulates EGFR localization and dynamics in filopodia.Video 3.EGFR-GFP cell culture filopodia.This video is related to [Figure 5](#fig5){ref-type="fig"}. Live imaging time-lapse video of axons from different primary neurons grown in culture for 4 days. UAS-EGFR^GFP^ is expressed with elav-Gal4 driver. Images were collected every 4 s.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.018](10.7554/eLife.01699.018)10.7554/eLife.01699.01810.7554/eLife.01699.019Figure 6.Differential EGFR localization in filopodial of primary Drosophila neurons requires endocytosis.(**A**--**A′**) UAS-EGFR^GFP^ expressed with elav-Gal4 driver in primary Drosophila neurons. False color image displaying a heat map of an EGFR^GFP^-expressing growth cone before (**A**) and after (**A′**) treatment with Dyngo. (**B**) Maximal intensity of EGFR^GFP^ in filopodia within one neuron over time (2 min), before and after treatment (indicated by dotted line) with Dyngo. (**C**) Scatter plot from EGFR^GFP^ maximal intensities from filopodia from 6 neurons, showing a significant decrease in levels after treatment with Dyngo (EGFR^GFP^ maximal intensities in DMSO: 1.229 ± 0.0074, n = 1403; EGFR^GFP^ maximal intensities in Dyngo: 0.768 ± 0.005, n = 1401, p\<0.001). (**D**) Effect of Dyngo on filopodia dynamics. Quantification of static vs dynamic (extensions and retractions) behaviors of filopodia shows a significant distribution change between controls (EGFR^GFP^-expressing neurons in DMSO) and Dyngo-treated EGFR^GFP^-expressing neurons (control: static = 28, dynamic = 72; Dyngo treated: static = 66, dynamic = 32, p\<0.001). Mann--Whitney test. \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.019](10.7554/eLife.01699.019)Video 4.Comparison egfr vs egfr + dingo.This video is related to [Figure 6](#fig6){ref-type="fig"}. Video shows the side-by-side comparison of dynamic behavior of filopodia with and without Dyngo-4a (a dynamin inhibitor) treatment. The intensity of the EGFR-GFP signal is displayed in yellow. The outlines of the filopodia have been segmented by subsequently thresholding and outline detection of the fluorescent signal. To show the dynamic behavior of the filopodia in the time-lapse video, the outlines of the following two frames (4 and 8 s ahead of the current frames) are displayed in red and in blue respectively. The untreated filopodia move more than the Dyngo-4a treated ones.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.020](10.7554/eLife.01699.020)10.7554/eLife.01699.020

EGFR signaling shows asymmetric localization and regulates differential filopodial dynamics in vivo {#s2-5}
---------------------------------------------------------------------------------------------------

Next, we asked if the EGFR is differentially localized and regulates branching dynamics in vivo. *EGFR* transcription ([@bib47]) and function in the *Drosophila* developing and adult brain have been documented, where it plays a role in neuronal survival ([@bib4]) and sleep regulation ([@bib15]). However, attempts to detect the EGFR protein using immunohistochemistry have thus far failed, most likely due to very low expression levels. We attempted to circumvent this problem by generating a genomic rescue construct tagged at the C-terminal end with GFP, identical to the UAS-EGFR^GFP^ used in our cell culture experiments. This construct rescues the embryonic lethality of EGFR null mutants to full adult viability with no visible defects. We examined the expression of genomic EGFR^GFP^ during brain development and find that it is broadly expressed in the developing neuropil, especially the distal medulla ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}), suggesting that EGFR signaling may be generally involved in the regulation of CNS connectivity. Indeed, inhibition of EGFR activity in the lateral neurons ventral (LNv) also causes excessive axonal branching ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Unfortunately, expression levels of the genomic EGFR^GFP^ transgene were too low to allow analysis at sub-cellular, single axon branch resolution. To examine subcellular EGFR distribution, we expressed UAS-EGFR^GFP^ in the DCNs. In DCNs, EGFR^GFP^ is detected in a punctate pattern in the cell bodies ([Figure 7A,B](#fig7){ref-type="fig"}, insets), along the axons and in axonal branches ([Figure 7---figure supplement 1C--E](#fig7s1){ref-type="fig"}). At ∼56 hr APF, when extensive growth and pruning occur, EGFR^GFP^ is unevenly distributed across different branches of the same axon ([Figure 7A--A‴](#fig7){ref-type="fig"}) and we find no stereotypic pattern across different individual axons or individual brains ([Figure 7---figure supplement 1F](#fig7s1){ref-type="fig"}). At ∼72 hr APF, after significant pruning has occurred, EGFR^GFP^ is distributed more uniformly across the remaining unrefined branches ([Figure 7B--B‴](#fig7){ref-type="fig"}). Note that both wildtype-untagged EGFR and EGFR^GFP^ do not change the DCN branching pattern ([Figure 7---figure supplement 4](#fig7s4){ref-type="fig"}), hinting that asymmetric receptor signaling is governed by differential receptor distribution, rather than total receptor levels per se. In the LNv, EGFR^GFP^ is expressed in cell bodies and low levels are present along the growing axons during development ([Figure 7---figure supplement 1G](#fig7s1){ref-type="fig"}). In contrast, in adult LNv UAS-EGFR^GFP^ becomes restricted to neuronal soma ([Figure 7---figure supplement 1G′](#fig7s1){ref-type="fig"}). Thus, remarkably, even overexpressed EGFR^GFP^ is present at relatively low levels and shows regulated developmental localization in different neuronal populations in vivo.10.7554/eLife.01699.021Figure 7.EGFR mediates a probabilistic branch refinement process.(**A**--**B**) EGFR localization examined by expressing UAS-EGFR^GFP^ (green) in the DCNs (red, UAS-cherryRFP) during pupal development at (**A**) 56 hr APF and (**B**) 72 hr APF. EGFR^GFP^ expression was observed in a punctate pattern in the cell bodies (insets in **A** and **B**) and along the axonal branches (**A** and **B**). Images **A**/**B** and **A′**/**B′** were subjected to thresholding and merged (**A‴**/**B‴**). Differential localization results in branches with (**A‴**, arrowheads) and without (**A‴**, arrows) EGFR^GFP^ at 56 hr APF, whereas most if not all branches contain EGFR^GFP^ at 72 hr APF (**B‴**, arrowheads). High magnification shows EGFR localization at branches at 56 hr APF (**A**~**2**~) and 72 hr APF (**B**~**2**~). (**C**) *Z*-stack projections from live imaging time-lapse videos of control axons at around 40 hr APF between t~0~ = 0 min (**C**~**1**~) and t~2~ = 10 min (**C**~**3**~) with 5-min intervals. (**D**) *Z*-stack projections from live imaging time-lapse videos of EGFR^DN^ axons at around 40 hr APF between t~0~ = 0 min (**D**~**1**~) and t~2~ = 10 min (**D**~**3**~) with 5 min intervals. Arrows indicate branches being pruned while arrowheads point to growing branches. (**E**) Visualization of growth (green) and retraction (purple) events between t~0~ = 0 min (**C**~**1**~) and t~1~ = 5 min (**C**~**2**~) in control. (**F**) Visualization of growth (green) and retraction (purple) events between t~1~ = 5 min (**D**~**2**~) and t~2~ = 10 min (**D**~**3**~) in EGFR^DN^. (**G**) Quantification of growth and retraction dynamics at branches using the tracer tool shows significant decrease in branch lengths in EGFR^DN^ compared to control. Control (growth) 7.75 ± 2.65 (n = 8), EGFR^DN^ (growth) 2.97 ± 0.56 (n = 9, p\<0.001). Control (retraction) 7.4 ± 2.28 (n = 8), EGFR^DN^ (retraction) 3 ± 1.08 (n = 8, p\<0.001). Horizontal lines represent the mean for each data set. *t* test. \*\*\*p\<0.001. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.021](10.7554/eLife.01699.021)10.7554/eLife.01699.022Figure 7---figure supplement 1.Localization of EGFR.(**A**) Expression of genomic EGFR^GFP^ (green) during brain development at 48 hr APF and the neuropil marked with DN-cadherin (blue). (**B**) Axonal arbor of lateral neurons ventral (LNv) (green) in wild type and EGFR^DN^. (**C**--**E**) EGFR localization by expressing *UAS-EGFR*^*GFP*^ (green) in the adult DCNs (red, UAS-cherryRFP) in one brain hemisphere (**C**), in the cell bodies (**D**) and in the axonal branches (**E**). The scale bars represent 20 µm except in **C** with 100 µm. (**F**) EGFR localization by expressing *UAS-EGFR*^*GFP*^ (green) in the DCNs (red, UAS-cherryRFP) of two different individual flies during pupal development at 56 hr APF. Differential localization results in branches with (arrowheads) and without (arrows) EGFR localization at 56 hr APF. The scale bars represent 20 µm. (**G**) EGFR localization examined by expressing UAS-EGFR^GFP^ (green) in the LNvs (red, UAS-lacZ) at (**G**) larval stage (L3) and in (**G′**) adult. The scale bar represents 60 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.022](10.7554/eLife.01699.022)10.7554/eLife.01699.023Figure 7---figure supplement 2.DCN branch pattern in cultured pupal brains.(**A**) DCN branch morphology of a brain dissected from pupae at 48 hr APF and then cultured under standard conditions ('Materials and methods') for 48 hr. Morphology of the neuropils has been visualized by nc82 staining (magenta). (**B**--**C**) Axon branch morphology in the optic lobe of pupal brain dissected at 48 hr APF and cultured for (**B**) 24 hr and (**C**) 48 hr. (**D**) EGFR shows differential and dynamic localization in developing dorsal cluster neurons in vivo. UAS-CD8-RFP and UAS-EGFR-GFP were expressed with ato-Gal4 in wild-type Drosophila brains. Intact eye--brain complexes were imaged live at 45% APF. Maximum projection images demonstrating a single DCN axon terminal from live imaging time-lapse videos at t = 0 min (left) t = 18 min (middle) and t = 46 min (right), for both channels (upper) and only EGFR channel (lower). Two directly opposing branches of the same DCN axon were followed over time. At t = 0 both branches have significant levels of EGFR signal (arrow and arrowhead). 18 min later upper (arrow) branch retains its EGFR signal while lower (arrowhead) branch demonstrates a significant decrease. 28 min later the lower branch demonstrates a slight increase in the signal while the upper branch almost completely loses it. Scale bars correspond to 5 µm in all images.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.023](10.7554/eLife.01699.023)10.7554/eLife.01699.024Figure 7---figure supplement 3.UAS-EGFR^GFP^ localizes and functions similar to endogenous EGFR.(**A**) Expression of UAS-EGFR-GFP in photoreceptor neurons at developing L3 eye disc using GMR-Gal4. (**A′**) Expression of endogenous EGFR revealed by immunohistochemistry on developing Canton-S L3 eye disc. The scale bars represent 20 µm. (**B**--**D′**) EGFR-GFP overexpression in the wing produces increase in vein tissue. (**B**) Control bearing Dpp-Gal4, showing the wild-type vein pattern, (**B′**) Zoom in of a ROI in (**B**). (**C**) Flies over-expressing wild-type-untagged EGFR in the wing using Dpp-Gal4 (along vein L3, black arrow) show a vein-specific increase in vein thickness (yellow arrow) and formation of ectopic veins (yellow arrowheads), (**C′**) zoom in of a ROI in (**C**). (**D**) Flies expressing EGFR-GFP using Dpp-Gal4 produces similar phenotypes to wild type EGFR over-expression (yellow arrow and arrowhead), (**D′**) zoom in of a ROI in (**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.01699.024](10.7554/eLife.01699.024)10.7554/eLife.01699.025Figure 7---figure supplement 4.Overexpression of wild-type EGFR does not cause a significant increase in axonal branching.Quantification of the number of axonal branches in DCNs overexpressing untagged or GFP-tagged EGFR. Neither causes a significant increase in the average number of axonal branches.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.025](10.7554/eLife.01699.025)

DCN branches develop and prune during pupal development when the brain is not easily accessible to live imaging. To overcome this limitation, we modified the protocol for long-term adult brain explant culture ([@bib1]) to support long-term pupal brain culture. This protocol supports the morphologically normal development of *Drosophila* pupal brains ([Figure 7---figure supplement 2A--C](#fig7s2){ref-type="fig"}). We sought to probe the basis of the regulation of developmental branch pruning by the EGFR. To this end, we performed high-resolution 4D live imaging to analyze real-time DCN axon branch formation by pairing the brain explant culture technique with resonant confocal microscopy of the cultured brains in a closed perfusion chamber ([@bib61]). Imaging of developing wild type pupal brains (40 hr--60 hr APF) shows that wildtype DCN axon branches are dynamic ([Video 5](#video5){ref-type="other"}). Branch growth and removal occurs within minutes and can span up to 11.5 μm within 5 min with an average of 7.5 μm during this period ([Figure 7C~1~--C~3~,E](#fig7){ref-type="fig"}). Furthermore, wildtype branches behave differently from each other, as indicated by the spread of growth and retraction speeds of different branches ([Figure 7G](#fig7){ref-type="fig"}). In contrast, the growth dynamics in the EGFR^DN^ expressing neurons are reduced in speed ([Video 6](#video6){ref-type="other"}). Growth and retraction processes of single branches are decreased to an average of 3 μm within 5 min and the dynamics show strikingly reduced variability between individual branches ([Figure 7D~1~--D~3~,F,G](#fig7){ref-type="fig"}). We wondered whether we could exploit the new developing brain culture system to ask whether EGFR is dynamically trafficked within DCN branches in vivo as these branches grow and retract. To this end, we generated flies expressing both EGFR-GFP and a red fluorescent protein (td-Tomato) in the DCNs. Live imaging ([Video 7](#video7){ref-type="other"}) of pupal brains from these animals and analysis of still images form these videos ([Figure 7---figure supplement 2D](#fig7s2){ref-type="fig"}) confirms that, like in primary neurons in culture, EGFR is trafficked dynamically as axons grows and retracts their branches in vivo; finally, it should be noted that EGFR^GFP^ shows similar localization and activity to its wild type counterpart ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}), in agreement with the fact that the identically tagged genomic construct rescues the null mutant to full viability.Video 5.brain culture WT 40 hr.This video is related to [Figure 7](#fig7){ref-type="fig"}. Live imaging time-lapse videos of control axons at around 40hr APF. Corresponds to images presented in [Figure 7C](#fig7){ref-type="fig"} and quantified in [Figure 7G](#fig7){ref-type="fig"}. Images were collected every 5 min for 45 min.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.026](10.7554/eLife.01699.026)10.7554/eLife.01699.026Video 6.brain culture EGFR-DN 40 hr.This video is related to [Figure 7](#fig7){ref-type="fig"}. Live imaging time-lapse videos of EGFR^DN^ axons at around 40hr APF. Corresponds to images presented in [Figure 7D](#fig7){ref-type="fig"} and quantified in [Figure 7G](#fig7){ref-type="fig"}. Images were collected every 5 min for 40 min.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.027](10.7554/eLife.01699.027)10.7554/eLife.01699.027Video 7.brain culture EGFR-GFP.This video is related to [Figure 7](#fig7){ref-type="fig"}. EGFR shows differential and dynamic localization in developing dorsal cluster neurons in vivo. UAS-CD8-RFP and UAS-EGFR-GFP were expressed with ato-Gal4 in wildtype *Drosophila* brains. Intact eye--brain complexes were imaged live at 45% APF. Maximum projection images demonstrating three DCN axon terminals in a time-lapse video of 3 hr with 2 min time intervals. Extension of the axons over time could be observed especially in the upper axon. All axons demonstrate rapid filopodial dynamics as well as changes in EGFR localization over time.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.028](10.7554/eLife.01699.028)10.7554/eLife.01699.028

Asymmetric EGFR signaling is essential for axon branch pruning through regulating actin localization {#s2-6}
----------------------------------------------------------------------------------------------------

To analyze downstream players of EGFR-dependent refinement we first focused on the canonical EGFR pathway. Activation of the MAPK cascade and transcriptional changes in the nucleus are main features of this pathway ([@bib56]). A nuclear marker for active MAPK signaling is double phosphorylated ERK (dpERK). Despite the fact that we verify expression in developing L3 eye disc ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}), we were not able to detect dpERK in developing DCN ([Figure 8---figure supplement 1B-B″](#fig8s1){ref-type="fig"}). One caveat is that activation of ERK might be difficult to detect due to low expression levels and timing issues. To further investigate if the canonical pathway is involved, we analyzed the effect of MAPK pathway genes ([@bib56]) on DCN axon refinement. Expression of Ras1^RNAi^, Drk ^RNAi^, a constitutively active form of ERK or a constitutively active form of Ras1 did not change the DCN branching pattern ([Figure 8---figure supplement 1C--G](#fig8s1){ref-type="fig"}). These results indicate that refinement occurs independently of the canonical EGFR pathway.

The fast growth and retraction rates of axonal branches in wildtype brains, altered growth dynamics upon EGFR inhibition and the well-established role for cytoskeletal proteins in branch formation ([@bib19]) together suggest that EGFR activation may act via cytoskeleton regulation in this case. We used actin-GFP ([@bib55]) and Utrophin-GFP ([@bib43]) expression in the DCNs to examine the distribution of total actin and filamentous actin (F-actin), respectively, in wild type vs EGFR^DN^ backgrounds. The F-actin binding protein Utrophin ([@bib18]) was utilized to analyze the distribution of actin filaments in wildtype and EGFR^DN^ axons. Utrophin-GFP reveals that F-actin is largely confined to the branches ([Figure 8A--A‴](#fig8){ref-type="fig"}, arrowheads) with low levels of F-actin in the axon shafts ([Figure 8A‴](#fig8){ref-type="fig"}, arrow) of wildtype brains. In contrast, in DCNs expressing EGFR^DN^ F-actin distribution appears weaker and more diffused over the axon shaft and axon branches ([Figure 8B--B‴](#fig8){ref-type="fig"}, arrowheads). Similar to F-actin, total actin-GFP concentrates at the branch tips ([Figure 8---figure supplement 2A--A‴](#fig8s2){ref-type="fig"}, arrowheads) and little actin is present within the main axon shaft. In contrast, in EGFR^DN^ DCNs total actin also accumulates in blebs along the entire length of the axons and their branches ([Figure 8---figure supplement 2B--B‴](#fig8s2){ref-type="fig"}, arrows). Axonal swellings have considerably lower F-actin accumulation ([Figure 8B‴](#fig8){ref-type="fig"}, asterisk) compared to total actin ([Figure 8---figure supplement 2B‴](#fig8s2){ref-type="fig"}, asterisk) suggesting that in EGFR^DN^ axons, monomeric actin is retained in axonal swellings along the axons, thus potentially inhibiting efficient actin polymerization dynamics at the branch tips.10.7554/eLife.01699.029Figure 8.EGFR regulates actin polymerization in DCN axonal branches.(**A**--**B**) Utrophin (F-actin) localization in adult DCN (red, UAS-cherryRFP) by expressing UAS-utrophin-GFP (green) in (**A**) control and (**B**) EGFR^DN^. (**A‴**--**B‴**) High magnification of the branch tips. Arrowheads show localization of Utrophin at the branch tips. Arrows show Utrophin localization along axon shafts. Asterisk in (**B‴**) shows weak Utrophin accumulation in axonal swellings. (**C**) Overexpression of a constitutively active form of EGFR (UAS-EGFR^CA^) results in increased branching in the adult DCN. (**C′**) Visualization of branches (purple) along a single main axon shaft (green), using the tracing tool. (**D**) Quantification of adult primary branch numbers per axons shows significant increase of branches in EGFR^CA^ compared to control. Control 6.96 ± 1.34 (n = 60), EGFR^CA^ 8.22 ± 1.47 (n = 55, p\<0.001). Error bars represent SEM. Mann--Whitney test. \*\*\*p\<0.001. (**E**--**H**) Axonal branch pattern at different pupal stages shows excessive branching during mid-pupal development. Branch morphology at (**E**) 36 hr APF, (**F**) 48 hr APF, (**G**) 60 hr APF, and (**H**) 72 hr APF.(**I**--**I′**) Utrophin (F-actin) localization in adult DCN (red, UAS-cherryRFP, **I′**) by expressing UAS-utrophin-GFP (green, **I**) in an EGFR^CA^ background. (**I″**) Merge of DCNs (red) and Utrophin (green). (**I‴**) High magnification of the branch tips. Arrowheads show localization of Utrophin at the branch tips. Arrowheads show localization of Utrophin at the branch tips. Arrows show Utrophin localization along axon shafts. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.029](10.7554/eLife.01699.029)10.7554/eLife.01699.030Figure 8---figure supplement 1.The canonical MAPK pathway is not involved in DCN refinement.(**A**) Localization of phosphorylated ERK (dpERK, red) in developing eye discs as readout for activated EGFR pathway. (**B**) Absence of dpERK (red, **B′**) at the DCN cell bodies (green, **B**) during pupal development. (**B″**) Merge of DCNs (green) and dpERK (red). (**C**--**F**) DCN branch pattern in neurons with genetically altered MAPK pathway activity by expression of (**C**) a constitutively active form of ERK (ERK^CA^), (**D**) Ras1^RNAi^, (**E**) a constitutively active form of Ras1 (Ras1^CA^) and (**F**) Drk ^RNAi^. (**G**) Quantifications of the genotypes in (**C**--**F**) do not reveal significant changes in DCN branch numbers compared to control. Control 6.96 ± 1.34 (n = 60), ERK^CA^ 7.43 ± 1.07 (n = 30), Ras1^RNAi^ 7.2 ± 1.71 (n = 59), Ras1^CA^ 7.07 ± 1.44 (n = 14), DRK^RNAi^ 7.36 ± 1.22 (n = 14). Non-parametric ANOVA Kruskal--Wallis test was not significant. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.030](10.7554/eLife.01699.030)10.7554/eLife.01699.031Figure 8---figure supplement 2.EGFR regulates actin polymerization in DCN axonal branches.(**A**--**C**) Actin localization in adult DCN (red, UAS-cherryRFP) by expressing UAS-Actin-GFP (green) in (**A**) control, (**B**) EGFR^DN^ and (**C**) EGFR^CA^. (**A‴**--**B‴**) High magnification of the branch tips. Arrowheads show localization of Actin at the branch tips. Arrows show actin localization along axon shafts. Asterisk in (**B**) shows total actin accumulation in axonal swellings. The scale bars represent 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.031](10.7554/eLife.01699.031)10.7554/eLife.01699.032Figure 8---figure supplement 3.Branch increase in cultured neurons by expression of EGFR^CA^.(**A**--**A′**) Overexpression of UAS-EGFR^CA^ using the *sca-Gal4* driver in neurons cultured for 2 days results in an increase of branches when compared to wild type (compare to [Figure 4A--A′](#fig4){ref-type="fig"}). For the visualization of branches, neurons were stained with anti-tubulin (green) and phalloidin (magenta). (**B**) Quantification of primary branch numbers per axon shows significant increase of branches in UAS-EGFR^CA^ neurons (control: 1 ± 0.05 (n = 235); EGFR^CA^: 1.37 ± 0.09; n = 120, p\<0.01). Error bars represent SEM. Mann--Whitney test. \*\*p\<0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.01699.032](10.7554/eLife.01699.032)

Our data thus far suggest a model whereby dynamic localization of the EGFR results in differential signaling between developing filopodia and axonal branches. This enhances actin dynamics and results in the proper balance of branch growth and pruning. However, an alternative possibility is that EGFR signaling simply instructs branch retraction. Both models predict increased branch numbers when EGFR signaling is inhibited. However, if EGFR signaling instructs branch pruning, activated EGFR would result in reduced axonal branching. In contrast, if EGFR signaling asymmetry is indeed required for the correct number of DCN axonal branches, then constitutive activation of the EGFR should also result in increased axonal branching. To distinguish between the two models, we analyzed the effect of a constitutively active form (UAS-EGFR^CA^). In agreement with a differential local signaling model, EGFR^CA^ induces a significant increase of DCN branches both in vitro ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}) and in vivo ([Figure 8C--D](#fig8){ref-type="fig"}) similar to down regulation of EGFR signaling. Importantly, similar to loss of EGFR function, the increase in branch number induced by gain of EGFR function is also due to reduced pruning during development ([Figure 8E--H](#fig8){ref-type="fig"}). Furthermore, in EGFR^CA^ axons total actin and F-actin also distribute more uniformly across the axonal projection ([Figure 8I--I‴](#fig8){ref-type="fig"}, [Figure 8---figure supplement 2C--C‴](#fig8s2){ref-type="fig"}, arrows), again suggesting reduction of efficient polymerization dynamics. In summary, EGFR signaling affects branch growth and retraction likely through the regulation of actin polymerization.

Discussion {#s3}
==========

The refinement of exuberant branches is a crucial step during the development of a neuronal network. In this work, we exploit an adult-specific model circuit, the dorsal cluster neurons, to study developmental neurite pruning processes in the CNS of *Drosophila*. DCN axons form a stereotyped number of branches innervating the medulla through initial excessive axon branch formation followed by a refinement process. Our data suggest a model ([Figure 9](#fig9){ref-type="fig"}) whereby uneven distribution of EGFR to developing DCN axonal branches is required to eliminate exuberant branches and help generate the correct adult connectivity pattern.10.7554/eLife.01699.033Figure 9.A model for EGFR function in axonal branching.Local asymmetries in tyrosine kinase receptor activity in axonal branch, driven by differential distribution of active receptor molecules in filopodia, generate dynamical behavior and drive branch pruning. Gray dots represent EGFR puncta trafficked along the axon shaft (red) while yellow dots represent active EGFR puncta within branches (green).**DOI:** [http://dx.doi.org/10.7554/eLife.01699.033](10.7554/eLife.01699.033)

During mammalian development neurites are generally formed in excessive numbers and subsequently refined to form the mature circuit ([@bib35]). This mechanism ensures that all targets are properly innervated, it enables further specification of connections by the target environment like neighboring neurons and glia ([@bib51]) and permits the removal of exuberant or mistargeted branches. Studying real-time events in the mammalian system involving CNS refinement is challenging. The *Drosophila* developing brain culture system used in this work combined with live imaging allows examination and manipulation of neuronal growth dynamics. Our data suggest that EGFR signaling, in part triggered by the co-innervation of the target neuropil by sensory neurons from the retina, is a crucial determinant of axonal branch refinement by the regulation of filopodial growth and retraction dynamics. Finally, we find that EGFR activity regulates actin polymerization dynamics at the branch tips. Consistent with this notion, we find that interfering with actin dynamics in vivo by inhibition of the small GTPase RhoA or constitutive activation of the actin filament severing protein Cofilin, is sufficient to cause ectopic axon branch formation in the DCNs (data not shown). EGFR expression has been observed in neurites of mammalian neurons ([@bib20]; [@bib8]) and knock-out of the EGFR in the mouse results in increased neurite branching in the skin ([@bib37]), suggesting that the mechanism we identify in the fly CNS may be more generally utilized.

In summary, we report evidence for the notion that differential branch signaling is a determinant of connection specificity. We show that intrinsically asymmetric EGFR localization and signaling is required for efficient branch pruning. Several lines of evidence support this conclusion. First, EGFR is asymmetrically localized in branches and filopodia both in vivo and in cultured primary neurons. Second, both inhibition and constitutive activation result in failure of axonal branch refinement. Third, overexpression of the wildtype receptor, which is differentially localized and trafficked, is not sufficient to produce a phenotype. This argues that receptor localization dynamics---possibly mediated by endocytosis---rather than total EGFR levels, is the cue for filopodial collapse and subsequent axonal branch pruning. What explains the link between regulation of dynamic behavior and the generation of a specific number of axonal branches? A hint to this comes from three observations. First, both loss and gain of EGFR function increase proportion of static filopodia from less than 10% to more than 30%, subsequently increasing the number of axonal branches. Second, this filopodial behavior correlates with small, but significant and highly dynamic differences in EGFR localization. Third, loss of EGFR signaling increases the variability in axon branch number. Based on these observations we propose that in wildtype neurons most dynamic filopodia collapse over time, resulting in continuous redistribution of EGFR among fewer and fewer remaining filopodia. This process stops usually when only one filopodium remains at a given branching point, and occasionally when EGFR happens to distribute equally between the last two filopodia. This probabilistic process does not require an additional mechanism of branch 'tagging and selection' and can explain both EGFR loss of function phenotypes: increased branch number and increased variability. What remains to be determined is the interaction between EGFR-dependent branch dynamics and the specificity of the spatial pattern of branches.

Materials and methods {#s4}
=====================

Fly strains and genetic manipulation {#s4-1}
------------------------------------

Fly stocks were cultured on standard fly food. All experiments were performed in temperature-controlled incubators at 25°C or 28°C. The GAL4 driver lines used in this study are: ato-Gal4-14a ([@bib24]), sca-Gal4, elav-Gal4. The UAS-reporter stocks were the following: UAS-CD8-GFP, UAS-CD8-cherryRFP, UAS-LacZ, UAS-EGFR^DN-A^ (gift from M Freeman)*,* UAS-EGFR^DN-B^*,* UAS-EGFR^RNAi^ (VDRC107130), UAS-Spi^RNAi^ (TRiP, JF03322), UAS-EGFR^CA^, UAS-Utrophin-GFP (gift from T Lecuit), UAS-Moesin-GFP ([@bib13]), lexAop-myr-GFP, ato^lexA^. Additional fly stocks and mutants used were: Canton-S, EGFR^T1^. For FLP-out system experiments *yw, hs-FLP; UAS-FRT CD2, y FRT mCD8::GFP; atoGal4-14a, UAS-LacZ* was crossed out to *Canton-S* or UAS-EGFR^DN-A^. *ato*^*LexA*^ was created by knocking LexA into the *ato* locus to drive LexAop-myr-GFP expression.

*Drosophila* primary neuron cultures {#s4-2}
------------------------------------

*Drosophila* primary neuron cultures were generated as described previously ([@bib45]; [@bib42]). In brief, stage 11 embryos (6--7 hr AEL at 25°C) were homogenised, treated for 5 min at 37°C with dispersion medium, washed and dissolved in Schneider's medium. Then, the aliquots were transferred to coverslips, kept as hanging drop cultures in airtight special culture chambers ([@bib11]) for 6 hr or 4 days at 26°C. Live imaging of primary neurons was performed on a Delta Vision (RT) (Applied Precision, Issaquah, WA) restoration microscope using a (100 × 3 phase) objective and the (Sedat) filter set (Chroma Technology, Germany). The images were collected using a Coolsnap HQ (Photometrics, Tuscon, AZ) camera, image acquisition was through Softworx. For immunocytochemistry, cells were fixed (30′ in 4% paraformaldehyde in 0.05 M phosphate buffer, pH 7.2), washed in PBS 0.1% Triton X-100 (PBT), then incubated with antisera diluted in PBT.

Inhibition of endocytosis and quantification {#s4-3}
--------------------------------------------

To inhibit endocytosis, cells were incubated for 6 min with 0.14 mM dynamin inhibitor Dyngo-4a (Abcam), diluted in Schneider's medium from stock solution in DMSO. For controls, equivalent concentrations of DMSO were diluted in Schneider's medium. The effect of the dynamin inhibitor Dyngo-4a on levels of EGFR^GFP^ was quantified in FIJI, by measuring the maximal intensities at the distal ends of filopodia during 2 min before and after drug treatment. Previous to quantification, the background of acquired images was subtracted (atrous wavelet transform, scales 1--8 minus low pass image). The GFP intensity of each filopodia was normalized to the mean of maximal intensities of all filopodia within a cell before and after treatment.

Immunohistochemistry {#s4-4}
--------------------

The following primary antibodies were used in the in vivo experiments: rabbit anti-GFP (1:1000; Invitrogen), mouse anti-GFP (1:500; Invitrogen), mouse anti β-galactosidase (1:1000; Promega), rabbit anti β-galactosidase (1:1000; Cappel), mouse MAb 24B10 anti-Chaoptin (1:200; DSHB), rabbit anti-DsRed (1:500; Clontech), mouse anti-NC82 (1:100; DSHB), rat anti-DN cadherin (1:20; DHSB DN-EX\#8). The following primary antibodies were used in the in vitro experiments: mouse anti-tubulin (1:1000; Sigma), goat anti-GFP (1:1000; Abcam). The incubation with the primary antibodies was followed by several washes in PBT (1 hr) and a final incubation with the appropriate fluorescent secondary antibodies (in vivo: *Alexa* 488, 555 or 647, Molecular Probes, 1:500, in vitro: FITC- or Cy3-conjugated affinity-purified secondary antibodies (donkey, 1:200 \[Jackson ImmunoResearch\])). In vitro filamentous actin was detected with TRITC-conjugated phalloidin (Sigma). After several washes in PBT the samples were mounted in vectashield.

Imaging {#s4-5}
-------

Confocal stacks of fixed brains were made using Zeiss LSM 510 or Leica SP6 confocal microscopes. Neuronal cell culture imaging was conducted with an AxioCam camera mounted on an Olympus BX50WI microscope. DCN live imaging was conducted with a Leica SP6 resonance scanning confocal microsocope. In general, a confocal stack comprising the axonal projection of Dorsal Cluster Neurons (30--40 single projections) was recorded every 5 min. Resonance scanning allowed high scan speed with lower laser intensities and therefore ensures preservation of living tissue due to decreased photo-toxicity. Projection images were generated and further processed with ImageJ. For tracking of axon branches we have used the 'simple neurite tracer' a plugin for ImageJ from Mark Longair (Fiji, <http://pacific.mpi-cbg.de>).

Quantification of developmental branches {#s4-6}
----------------------------------------

Images of medulla axons were skeletonized and subsequently automatically analyzed using the 'Skeletonize3D' and 'AnalyzeSkeleton' free plugins for ImageJ/FIJI (freely downloadable from the FIJI website: URL: <http://pacific.mpi-cbg.de/wiki/index.php/Fiji>). Number of developmental branches is the number of end points from the skeleton.

Whole pupal brain culture system and live imaging {#s4-7}
-------------------------------------------------

Staged pupal brains were dissected in cold Schneider's Drosophila Medium (GIBCO) and transferred to the culture plate inserts and cultured according to the whole brain explant system described previously ([@bib1]). After allowing the pupal brains to attach to the membrane of the culture plate insert for a minimum of 8 hr, the membrane was cut out of the plastic insert and carefully transferred to a closed confocal imaging perfusion chamber (Harvard IC30 confocal imaging chamber) connected to a peristaltic pump that slowly perfuses culture solution over the live tissue. A fast resonant scanning confocal microscope (Leica TCS SP5) with special high-aperture immersion lenses was used to allow three-dimensional recordings over time at faster frame rates which reduces phototoxicity. Live imaging was performed as previously described ([@bib61]).

Quantification of live imaging {#s4-8}
------------------------------

For tracking of growth and retraction dyamics we have used the 'simple neurite tracer' a plugin for ImageJ from Mark Longair (Fiji, <http://pacific.mpi-cbg.de>). We have traced dynamic axon branches by using the tip of an axon at time point t~0~ as starting point and the tip of the same axon at time point t~1~. The length of the resulting fragment represents the length of the growing or retracting axon.

Generation of UAS-EGFR^GFP^ transgenic flies {#s4-9}
--------------------------------------------

UAS-EGFR^GFP^ was created by fusing the *Drosophila egfr* cDNA from the pUC13-DERII construct ([@bib47]) and *eGFP* cDNA (Clontech) from pStinger into *pUAST-Attb* vector (Genbank EF362409.1). Two Gly-Gly-Ser bridges (GGSGGS) have been introduced between the two open reading frames. Transgenic flies were created at GenetiVision Inc. (Houston, USA) using PhiC31-mediated transgenesis in the VK37 docking site (2L, 22A3) and in the VK31 docking site (3L, 62E1).

EGFR^GFP^ measurements in cultured neurons {#s4-10}
------------------------------------------

Levels of *EGFR*^*GFP*^ in static vs dynamic filopodia were quantified in FIJI, by drawing a box at the distal ends of filopodia and measuring the maximal intensities within. Only neurons with both static and dynamic filopodia were used for the analysis, and the GFP intensity of each filopodia was normalized to the mean of maximal intensities of all filopodia within a cell. For dynamic filopodia, measurements were taken during the first 8 s of the retraction or extension. For static filopodia, measurements were taken during 8 s at the middle of the recording period. These measurements were used to calculate the ratio of EGFR^GFP^ in dynamic minus static filopodia (GFP maximal intensity of each dynamic phase minus the mean of GFP maximal intensity in static filopodia).

Statistical tests {#s4-11}
-----------------

For non-normally distributed samples the nonparametric ANOVA Kruskal--Wallis test with Dunn's multiple comparisons for [Figure 2E](#fig2){ref-type="fig"} and the Mann--Whitney test for [Figure 8D](#fig8){ref-type="fig"} was performed. Student's *t* test was used for [Figures 3P and 7G](#fig3 fig7){ref-type="fig"}. For neuronal culture experiments, the Mann--Whitney test was used for [Figure 4C,F, 5C and 6D](#fig4 fig5 fig6){ref-type="fig"}.

Materials and methods for figure supplements and videos {#s4-12}
-------------------------------------------------------

### Fly strains and genetic manipulation {#s4-12-1}

The additional GAL4 driver line was: GMR-Gal4 and Dpp-Gal4. The UAS-reporter stocks were the following: UAS-nSyb-GFP, UAS-Syt-GFP, UAS-ERK^CA^, UAS-Ras1^CA^, UAS-Ras1^RNAi^, UAS-Drk^RNAi^, UAS-Actin-GFP, UAS-EGFR. Additional fly stocks and mutants used were: Vein-lacZ (gift from I Miguel-Aliaga), EGFR^1k35^, Spi^scp2^.

For MARCM experiments ([@bib33]) *yw; hsflp, UAS-CD8-GFP; FRT42D Tub-Gal80/ CyO; atoGal4-14a/TM6c* were used in conjunction with *yw; FRT42D EGFR*^*1k35*^*/ CyO*. The crosses were set up at 25°C and transferred every day. 2 to 4 days after egg laying the samples were heatshocked for 3 hr at 37°C and shifted back to 25°C until eclosion.

### Immunohistochemistry {#s4-12-2}

The following primary antibodies were used in this study: rat anti-DN cadherin (1:20; DHSB DN-EX\#8), rat anti-EGFR (1:1,000, from B Shilo), rabbit anti-dpERK (1:100; Cell Signaling), mouse anti-NC82 (1:100; DSHB), Rabbit anti Rab5 (1:500; Abcam), Rat anti Rab11 ([@bib12], 1:500).

### *Drosophila* long-term pupal brain culture {#s4-12-3}

Culture medium was modified from [@bib1]. The culture medium contained 5000 U/ml penicillin, 5 mg/ml streptomycin, 10% fetal bovine serum, 20 µg/ml insulin and 2 µg/ml of ecdysone in Schneider's Insect Medium. Pupal brains were dissected in room temperature culture medium and immediately placed in a sterile culture dish containing fresh medium. Brains remained undisturbed in the dark at 25°C throughout the culture period. At the end of the culture period the brains were rinsed briefly in PBS and then fixed in 2% paraformaldehyde for 1 hr followed by standard Immunohistochemistry.

### Live culture and imaging of EGFR^GFP^ in DCNs {#s4-12-4}

Intact pupal eye--brain complexes dissected from 45% APF *Drosophila* were cultured in a Schneider's based medium ([@bib1]), immobilized in 0.4% agarose solution. Confocal stacks of DCN terminals were captured every 2 min using a Leica SP5 resonant scanner for 3 hr, with a 63X (NA = 1.3) glycerol objective. Images were deconvolved using Autoquant X3 (Media Cybernetics) and analyzed with Imaris 7.6 (Bitplane).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Regulation of branching dynamics by axon-intrinsic asymmetries in Tyrosine Kinase Receptor signaling" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 2 reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewer discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

In the present study, Zchatzch and collaborators demonstrate a novel role for EGF receptor signaling in axon branching. Using Drosophila adult brain neurons as a model, the authors provide comprehensive evidence for the instrinsic role of EGFR in regulating terminal axon branching by controlling the dynamics of filopodia. This evidence is based on a comprehensive set of experimental approaches including genetic gain- and loss-of-function, single cell analysis and time-lapse microscopy using an innovative ex vivo preparation. Furthermore, the authors explore the downstream signaling pathway that might underlie this unconventional function for EGFR and demonstrate that it is not involving a \'canonical\' set of tyrosine kinase receptor signaling (Ras-MAPK signaling). Finally, the authors explore the involvement of actin dynamics and show that EGFR signaling in axon branching involves a control of F-actin polymerization in axonal filopodia.

This article is clearly providing novel insights into the cellular and molecular mechanisms underlying axon branching in vivo, which is a highly significant aspect of brain wiring. Therefore, the significance of results is high. However, one reviewer raised a number of substantial concerns regarding some aspects of the work, focusing on: First, the loss and gain of function of EGFR causes the same effect in branching. It is true that there might be a way to interpret this, but the understanding of the downstream signaling events is not sufficient to validate the model. Second, endocytosis blockade led to a decrease of the receptor level. This is not intuitive and needs to be explored further. Third, the subcellular localization of EGFR is very interesting. However, the correlation between the presence of EGFR in vivo and the fate of branches is not established.

Therefore, we would like to have the authors respond to the major comments listed below. If they can provide experimental evidence for most of the major points (with a strong priority for point 4 below), we will be happy to consider a revised version.

Major comments:

1\) [Videos 1 and 2](#video1 video2){ref-type="other"} seem to show very different modes of movements. In [Video 1](#video1){ref-type="other"}, it seems that vesicular transport can be seen. [Video 2](#video2){ref-type="other"} shows a much more diffused staining pattern. The intensity changes in this video seem to be fluctuations instead of discrete vesicular movements.

2\) It is usually assumed that inhibition of endocytosis would lead to an increase in the level of receptors on the membrane. [Figure 6](#fig6){ref-type="fig"} showed the opposite. First, is it known whether the EGFR is mostly on the surface or internal? The main limitation of using a simple EGFP fusion protein is that the authors cannot distinguish between surface receptor from internal stores present in endosomes/exosomes. Second, it is entirely possible that the authors are correct and some type of transcytosis (which requires endocytosis) is sending EGFR to the filopodia. Is there any redistribution of EGFR from the cell body or primary axon to the branches?

3\) In [Figure 7](#fig7){ref-type="fig"}, the authors use overexpressed EGFR-GFP to study the subcellular localization of EGFR. Does this construct cause there any effect on the branching phenotype? In the EGFR^DN^ background, does the EGFR-GFP rescue the phenotype? This is of course trying to test if the EGFR-GFP construct is functional.

4\) The critical experiment is to understand the correlation of having strong EGFR-GFP puncta on a branch and whether they will be pruned in [Figure 7](#fig7){ref-type="fig"}. We did not get a clear answer whether that has been attempted or not from the text.

5\) In [Figure 7C](#fig7){ref-type="fig"}, both growth and retraction of neurites are severely affected by the DN construct. The effects on the growth of the neurite are inconsistent with the lack of outgrowth phenotype in the loss-of-function analyses, which challenges the relevance of this long-term culture system.

6\) It is puzzling that the gain-of-function EGFR causes the same phenotype as the loss-of-function. Although the authors have a way of thinking about this result, detailed analyses of the EGFR^CA^ during the developmental course is necessary to test if the loss- and gain-of-function manipulation indeed has the same effects in growth and pruning.

7\) It is unclear what is the cellular source of EGF ligand(s). The results implicate that EGF ligand(s) could act in an \'axon-autonomous\' way to control branching through filopodia through contacts between filopodia of adjacent axons. However, the authors never document where EGF ligand(s) are located. Are there expressed by the axons themselves or by adjacent cells or both? In situ hybridization for the ligand(s) such as Spitz might clarify this important point.

10.7554/eLife.01699.035

Author response

*1)* [*Videos 1 and 2*](#video1 video2){ref-type="other"} *seem to show very different modes of movements. In* [*Video 1*](#video1){ref-type="other"}*, it seems that vesicular transport can be seen.* [*Video 2*](#video2){ref-type="other"} *shows a much more diffused staining pattern. The intensity changes in this video seem to be fluctuations instead of discrete vesicular movements*.

[Video 2](#video2){ref-type="other"} was only meant as an example for the method of using a heat intensity scale in order to quantify the degree of GFP fluorescence filopodia relative to background fluorescence, as shown in [Figure 5](#fig5){ref-type="fig"}. We now provide a new video of a primary neuron to show that EGFR motility in axons, branches and filopodia does indeed look very much like vesicular transport ([Video 3](#video3){ref-type="other"}). Furthermore, we provide evidence that EGFR-GFP puncta partially co-localize with both Rab5 and Rab11, suggesting that EGFR is present on early and recycling endosomes ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}). Finally, we have succeeded in performing live imaging on EGFR-GFP in DCNs on whole brain cultures and show that it is trafficked dynamically in and out of branches and filopodia in vivo ([Video 7](#video7){ref-type="other"}).

*2) It is usually assumed that inhibition of endocytosis would lead to an increase in the level of receptors on the membrane.* [*Figure 6*](#fig6){ref-type="fig"} *showed the opposite. First, is it known whether the EGFR is mostly on the surface or internal? The main limitation of using a simple EGFP fusion protein is that the authors cannot distinguish between surface receptor from internal stores present in endosomes/exosomes. Second, it is entirely possible that the authors are correct and some type of transcytosis (which requires endocytosis) is sending EGFR to the filopodia. Is there any redistribution of EGFR from the cell body or* *primary axon to the branches?*

Indeed we find EGFR is trafficked from cell bodies and main axon shafts in and out of filopodia. We now show this and in cultured neurons ([Video 3](#video3){ref-type="other"}) and in vivo ([Figure 7--figure supplement 1C-E](#fig7s1){ref-type="fig"}). Furthermore, we provide evidence that EGFR-GFP puncta partially co-localize with both Rab5 and Rab11, suggesting that EGFR is present on early and recycling endosomes ([Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}). It should be stated that endocytosis regulates spatial distribution of EGFR signaling in various epithelial cell types in vitro (reviewed in Ceresa, 2013). Our data demonstrate that this is also true in neurons in vivo.

*3) In* [*Figure 7*](#fig7){ref-type="fig"}*, the authors use overexpressed EGFR-GFP to study the subcellular localization of EGFR. Does this construct cause there any effect on the branching phenotype? In the EGFR*^*DN*^ *background, does the EGFR-GFP rescue the phenotype? This is of course trying to test if the EGFR-GFP construct is functional*.

Both wild type untagged EGFR and tagged EGFR-GFP cause no phenotypes when overexpressed in DCNs. This is likely because, as shown in [Figure 7](#fig7){ref-type="fig"} and its supplements, EGFR protein levels -- even when highly overexpressed -- are very tightly regulated and only readily detectable upon antibody staining. Furthermore, wild type EGFRs (tagged and untagged) are still regulated by ligand availability, which is not the case for EGFR^DN^ and EGFR^CA^.

When overexpressed in the eye EGFR-GFP shows similar eye defect phenotype to the overexpressed untagged wild type receptor, as stated in the original manuscript. In addition, we now show that it displays similar localization in the eye as the endogenous receptor ([Figure 7--figure supplement 3A, A'](#fig7s3){ref-type="fig"}).

Most importantly, as shown in the original manuscript ([Figure 7--figure supplement 1](#fig7s1){ref-type="fig"}) a genomic EGFR-GFP construct, tagged at *precisely* the same position as the EGFR cDNA, fully rescues the EGFR null mutant from embryonic lethality to adult viability. These data strongly argue that the GFP-tagged EGFR is fully functional.

To formally test this, we cannot ask if the UAS-EGFR-GFP rescues the dominant negative, wild type EGFR-GFP is still subject to inhibition by dominant negative EGFR. Instead, we turned to a classical assay that is used to gauge EGFR activity in vivo. Formation of the wing veins in flies requires spatially restricted EGFR activity. When wild type EGFR is expressed in the developing wing outside the normal vein domains, it causes the formation of ectopic vein tissue (e.g., Hahn et al. 2013). We find that both a control untagged wild type EGFR and EGFR-GFP cause equivalent ectopic wing vein formation ([Figure 7--figure supplement 3B-D'](#fig7s3){ref-type="fig"}). Altogether, our data show that a GFP tag in the C-terminus of EGFR does not compromise its activity in vivo.

*4) The critical experiment is to understand the correlation of having strong EGFR-GFP puncta on a branch and whether they will be pruned in* [*Figure 7*](#fig7){ref-type="fig"}*. We did not get a clear answer whether that has been attempted or not from the text*.

To address this question in vivo ([Figure 7](#fig7){ref-type="fig"} shows in vivo data) requires simultaneous live imaging of EGFR-GFP and DCN filopodia over a 48 hour time scale to ascertain definitively which filopodia will become the stable branches and how they behaved over a 48 hour period in relation to the level of EGFR-GFP they contain. While live imaging of DCN filopodia is currently feasible over a period of 2-4 hours ([Videos 5 and 6](#video5 video6){ref-type="other"}), continuous live imaging over several days in these brain cultures is not yet possible. It should be noted that in this case one would be attempting to correlate events that take place on the scale of seconds (EGFR trafficking) with events that take place on the scale of minutes (filopodial growth and collapse), with their ultimate consequences, which take place on the scale of days (i.e., the final loss or stabilization of a branch). Furthermore, both genomic and even overexpressed EGFR-GFP are almost undetectable in brain neurons without anti-GFP antibody staining, as stated in the original manuscript. We find this to be true not only in DCNs but also in other neurons, such as LNv, also as stated in the original manuscript. For all these reasons, we had reasoned that the weakness of the signal in unstained brains precludes live imaging of EGFR-GFP puncta in DCN filopodia in vivo. This is why we performed these experiments in cultured primary neurons ([Figure 5 and its supplement](#fig5 fig5s1 fig5s2){ref-type="fig"}). As stated in the original manuscript we find that small, but highly significant (p \< 0.0001) differences in EGFR levels correlate with increased filopodial dynamics, both growth and retraction.

To address at least in part this important concern, we asked whether EGFR can be detected trafficking in and out of filopodia, as these filopodia move in vivo. To this end, we generated flies and developed a setup that allows high resolution imaging of EGFR-GFP movement while monitoring filopodial motion. These data ([Video 7](#video7){ref-type="other"} and [Figure 7--figure supplement 2D](#fig7s2){ref-type="fig"}) show clearly that EGFR-GFP puncta continuously enter and exit filopodia as filopodia continue to move.

Altogether, our data provide strong evidence to support the notion that dynamic asymmetries in EGFR distribution are essential for proper axonal branching and that wiping out those differences in both EGFR-DN and EGFR-CA backgrounds grinds filopodial dynamics to a virtual halt causing failure of axonal branch pruning.

*5) In* [*Figure 7C*](#fig7){ref-type="fig"}*, both growth and retraction of neurites are severely affected by the DN construct. The effects on the growth of the neurite are inconsistent with the lack of outgrowth phenotype in the loss-of-function analyses, which challenges the relevance of this long-term culture system*.

The effects on filopodia in EGFR loss-of-function conditions are not on the initial growth of filopodia per se (i.e., not on filopodia formation). Inhibition of EGFR stops *changes* in growth. In other words existing filopodia show reduced *net* growth and retraction after they have initially formed. The graph in [Figure 7](#fig7){ref-type="fig"} shows the *difference* in growth and retraction rates between the genotypes and *not* the total length of filopodia. Thus, in EGFR-DN flies, initially formed filopodia no longer undergo dynamic changes, and therefore remain mostly static and develop into the excessive branches we observe in vivo. We have now changed the graph heading to reflect this and labeled the graphs as ΔGrowth and ΔRetraction to avoid the confusion we may have caused.

*6) It is puzzling that the gain-of-function EGFR causes the same phenotype as the loss-of-function. Although the authors have a way of thinking about this result, detailed analyses of the EGFR*^*CA*^ *during the developmental course is necessary to test if the loss- and gain-of-function manipulation indeed has the same effects in growth and pruning*.

In classical binary signaling paradigm, it is indeed puzzling that loss- and gain-of-function of a signal cause the same phenotype. However, what we show is that the asymmetry of EGFR signaling is essential for filopodial motion and thus we infer that any manipulation that interferes with the dynamic localization of the EGFR is likely to cause the same defect. However, as the reviewer suggests, the same final phenotype may result from different types of developmental effects. To this end, we have performed a developmental analysis of EGFR^CA^ and find that gain of EGFR function inhibits axonal branch pruning during development, mimicking the effects of EGFR loss of function ([Figure 8E-H](#fig8){ref-type="fig"}). Again, these data provide strong evidence to support the notion that dynamic asymmetries in EGFR distribution are essential for proper axonal branching.

*7) It is unclear what is the cellular source of EGF ligand(s). The results implicate that EGF ligand(s) could act in an \'axon-autonomous\' way to control branching through filopodia through contacts between filopodia of adjacent axons. However, the authors never document where EGF ligand(s) are located. Are there expressed by the axons themselves or by adjacent cells or both? In situ hybridization for the ligand(s) such as Spitz might clarify this important point*.

Our genetic (Spitz) and enhancer-reporter (Vein) data indicate that these two ligands as the likely sources of EGF activity. Spitz is likely provided by retinal axons, and not DCN axons and is thus not axon-autonomous. Therefore, in situ hybridization for the *spitz* mRNA is unlikely to reveal RNA at the axonal level. Vein is likely provided by cells adjacent to DCN axons, as shown by the Vein-LacZ reporter transgene. Furthermore, a more recent study shows that an overexpressed Spitz-GFP transgene is secreted from photoreceptor axon terminals ([@bib63]), as stated in the original manuscript. To our knowledge, there are currently no Spitz antibodies that work in vivo. We were not able to find references in the recent literature (last 10 years) to such reagents. A 1998 paper (Huang et al.) does report endogenous Spitz protein expression all along the axons of all photoreceptors, consistent with our genetic evidence. We acquired the same antibody used in the 1998 study, but find that the reagent does not appear to work any longer. We were unable to detect any Spitz expression, including in positive control tissue such as the developing retina.

[^1]: Department of Physiology, University of Texas Southwestern Medical Center, Dallas, United States.

[^2]: Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
